- DOI:
-
https://doi.org/10.57187/5508
Special article
Vol. 156 No. 9 (2026)
The importance of reporting notifiable infectious diseases – the Swiss reporting system
-
Cite this as:
-
Swiss Med Wkly. 2026;156:5508
-
Published
-
25.09.2026
Summary
The structured processes of clinical medicine and epidemiology are closely aligned, with disease reporting serving as the critical interface between individual patient care and population-level public health action. In Switzerland, mandatory reporting of communicable diseases forms the backbone of national infectious disease surveillance and relies on coordinated contributions from clinicians and laboratories. The Swiss reporting system is regulated by an ordinance that defines notifiable diseases, reporting criteria and strict timelines. It encompasses severe diseases, outbreak-prone infections, and endemic or vaccine-preventable conditions, and is continuously updated to reflect evolving epidemiological threats. Accurate case classification depends on the integration of both clinical and laboratory data; incomplete reporting compromises data quality and can lead to misclassification and biased epidemiological conclusions.
In recent years, reporting compliance – particularly for clinical notifications – has declined significantly. This deterioration in data completeness limits the ability to detect outbreaks, assess trends and implement timely and targeted public health interventions. Contributing factors include administrative burden, limited awareness of reporting obligations and insufficient understanding of the public health value of reporting.
High-quality reporting is essential for multiple public health functions: enabling rapid containment measures such as contact tracing and isolation, supporting outbreak detection through statistical surveillance and genomic analysis, informing national health policies and vaccination strategies, and facilitating research. Surveillance data are routinely analysed and disseminated via national dashboards and international collaborations.
In conclusion, although reporting imposes additional demands on clinicians, it remains a fundamental component of effective public health practice. Strengthening reporting compliance and data quality is critical to ensuring timely interventions, reducing disease burden and maintaining resilient health systems. Improved digital solutions may alleviate reporting burdens; however, sustained clinician engagement and recognition of their role in public health are indispensable.
References
- 1. World Health Organization (WHO). Communicable disease surveillance and response systems: guide to monitoring and evaluating [Internet]. Geneva: WHO; 2006. Available from: https://apps.who.int/iris/handle/10665/69331
- 2. Federal Department of Home Affairs (FDHA). Ordinance of the FDHA on the reporting of observations of communicable diseases in humans [Internet]. Bern: FDHA; 2015. Available from: https://www.fedlex.admin.ch/eli/cc/2015/892/de
- 3. Federal Office of Public Health (FOPH). Guidelines on mandatory reporting of communicable diseases and pathogens, 2026 [Internet]. Bern: FOPH; 2026. Available from: https://www.bag.admin.ch/dam/de/sd-web/MDjbgfEN6jEf/leitfaden-zur-meldepflicht.pdf
- 4. Swiss Society for Infectious Diseases (SSI). SSI Guidelines [Internet]. Switzerland: SSI. Available from: https://ssi.guidelines.ch/
- 5. European Commission. Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Off J Eur Union. 2018 Jul 6;L170:1–74.
- 6. Federal Office of Public Health (FOPH). Infectious Diseases Dashboard (IDD): epidemiological data on communicable diseases in Switzerland [Internet]. Bern: FOPH. Available from: https://www.idd.bag.admin.ch
- 7. Swiss Confederation. Federal Act on the Control of Communicable Human Diseases (Epidemics Act, EpA) of 28 September 2012 (Status as of 1 January 2016). Bern: Swiss Confederation; 2015.
- 8. Ingelbeen B, van Kleef E, Mbala P, Danis K, Macicame I, Hens N, et al. Embedding risk monitoring in infectious disease surveillance for timely and effective outbreak prevention and control. BMJ Global Health. 2025 Feb;10(2):e016870. doi:10.1136/bmjgh-2024-016870
- 9. Madhav N, Oppenheim B, Gallivan M, Mulembakani P, Rubin E, Wolfe N. Pandemics: risks, impacts, and mitigation. In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, editors. Disease Control Priorities: improving health and reducing poverty. Washington (DC): World Bank; 2017. p. 315–45.
- 10. Speich C, Stephan R, Dhima N, Hollenstein F, Horlbog J, Delvento G, et al. Rapid detection of the source of a Listeria monocytogenes outbreak in Switzerland through routine interviewing of patients and whole-genome sequencing. Swiss Med Wkly. 2024;154(5):3745. doi:10.57187/s.3745
- 11. Federal Office of Public Health (FOPH). National programme (NAPS): Stop HIV, hepatitis B, hepatitis C virus and sexually transmitted infections [Internet]. Bern: FOPH. Available from: https://www.bag.admin.ch/de/nationales-programm-naps-stopp-hiv-hepatitis-b-hepatitis-c-virus-und-sexuell-uebertragene-infektionen
- 12. Federal Office of Public Health (FOPH). Swiss vaccination plan [Internet]. Bern: FOPH. Available from: https://www.bag.admin.ch/de/schweizerischer-impfplan
- 13. Federal Office of Public Health (FOPH). Ergänzende Impfempfehlungen zum Schutz vor invasiven Meningokokken-Erkrankungen. BAG Bulletin. 2024 Jan 15;3:8–17. Available from: https://www.bag.admin.ch/dam/de/sd-web/WLKyt5OaIfqj/bu-3-24.pdf
- 14. Fischer FB, Saucy A, Vienneau D, Hattendorf J, Fanderl J, de Hoogh K, et al. Impacts of weather and air pollution on Legionnaires' disease in Switzerland: a national case-crossover study. Environ Res. 2023;220:115123. doi:10.1016/j.envres.2023.116327
- 15. Steinle S. Public Health und Ärzteschaft: zwei Perspektiven, ein Auftrag. Schweiz Ärztezeitung. 2026 Feb;107(1):14–18.